Difference between revisions of "Amyloid beta A4 peptide"
m |
|||
| (5 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
| − | ! | + | ! {infobox header}| '''{{PAGENAME}}''' |
|- | |- | ||
| − | | align="center" colspan="2" bgcolor="#ffffff" | [[Image: | + | | align="center" colspan="2" bgcolor="#ffffff" | [[Image:Beta_amyloid.JPG|200px|{{PAGENAME}}]] |
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
| Line 40: | Line 40: | ||
|- | |- | ||
| Surface accessibility | | Surface accessibility | ||
| − | | [http://gibk21.bse.kyutech.ac.jp/asaview/all/ | + | | [http://gibk21.bse.kyutech.ac.jp/asaview/all/1aml.pdf ASAView] pdf |
| + | [http://gibk21.bse.kyutech.ac.jp/asaview/all/1aml.txt ASAView] txt | ||
|- | |- | ||
| Disorder prediction | | Disorder prediction | ||
| Line 51: | Line 52: | ||
| | | | ||
|- | |- | ||
| − | | {{infobox header | + | | Video |
| + | |{{#ev:dailymotion|7qzKHArw798dckRrh|300}} | ||
| + | |- | ||
| + | | {infobox header} | | ||
|- | |- | ||
|} | |} | ||
[[Category:Tissue transglutaminase|*]] | [[Category:Tissue transglutaminase|*]] | ||
Latest revision as of 11:23, 10 March 2015
| Amyloid beta A4 peptide | |
|---|---|
| |
| Substrate peptide name | Amyloid beta A4 peptide |
| Synonyms | Alzheimer disease amyloid protein |
| Determination type | In vitro |
| Source | Homo sapiens |
| Subcellular localization | Extracellular; cerebrospinal fluid
Alzheimer's disease neuritic plaques |
| Swissprot ID | P05067 |
| Reactive glutamines | Q15 |
| Reactive lysines | K16, K28 |
| Substrate sequence | YEVHHQKLVFFA
DVGSNKGAIIG |
| Structure | 1AML |
| Surface accessibility | ASAView pdf
ASAView txt |
| Disorder prediction | IUPred |
| Reference | PMID:7905838 |
| Notes | |
| Video | 7qzKHArw798dckRrh|300}} |
